| View |
|
DR-XY42139
|
Tolnaftate
|
Healthcare Tinea
|
10mg/mL (1% w/v)
|
Topical Solution
|
Antifungals
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
02 March 2023
|
20 June 2028
|
| View |
|
DR-XY42145
|
D-Alpha Tocopherol (Vitamin E)
|
FAIRY-E
|
400 IU
|
Softgel Capsule
|
VITAMIN
|
Northfield Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 June 2023
|
19 June 2028
|
| View |
|
DR-XY42147
|
Tafluprost
|
Taflotan
|
15 mcg/mL (0.0015%)
|
Ophthalmic Solution
|
Antiglaucoma preparations and Miotics
(Prostaglandin analogues)
|
Santen Pharmaceutical Co., Ltd.
|
Japan
|
Automatic Renewal
|
23 June 2021
|
25 June 2026
|
| View |
|
DR-XY42149
|
Valsartan
|
Valsajub
|
160 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor blocker
|
Jubilant Generics Limited
|
India
|
Renewal
|
21 March 2023
|
26 June 2028
|
| View |
|
DR-XY42152
|
Valsartan
|
Valsajub
|
80 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor blocker
|
Jubilant Generics Limited
|
India
|
Automatic Renewal
|
12 March 2023
|
26 June 2028
|
| View |
|
DR-XY42155
|
Candesartan Cilexetil
|
Atasart
|
16mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Automatic Renewal
|
02 February 2023
|
01 July 2028
|
| View |
|
DR-XY42156
|
Candesartan Cilexetil
|
Atasart
|
8mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Automatic Renewal
|
05 January 2023
|
01 July 2028
|
| View |
|
DR-XY42162
|
Hyoscine N-Butylbromide
|
Hiospan
|
10mg
|
Tablet
|
Anticholinergic
|
UPHA Pharmaceutical Mfg. (M) Sdn. Bhd.
|
Malaysia
|
Automatic Renewal
|
28 February 2023
|
26 June 2028
|
| View |
|
DR-XY42163
|
Clindamycin (As Phosphate)
|
Vagilin
|
100 mg
|
Soft Gelatin Capsule (For Vaginbal Use)
|
Antibacterial (Lincosamide)
|
Gelnova Laboratories (India) Pvt. Ltd.
|
India
|
Automatic Renewal
|
28 June 2023
|
27 June 2028
|
| View |
|
DR-XY42164
|
Atorvastatin (as calcium)
|
Onestatin
|
10 mg
|
Film-Coated Tablet
|
Antihyperlipidaemic
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
15 June 2023
|
27 June 2028
|
| View |
|
DR-XY42169
|
Ondansetron (as Hydrochloride Dihydrate)
|
Onsia
|
2 mg/mL (4 mg/2 mL)
|
Solution for Injection (I.M/I.V)
|
Antiemetic (Serotonin (5HT3) Antagonist}
|
Siam Bheasach Co., Ltd.
|
Thailand
|
Initial (Variation)
|
24 August 2023
|
24 August 2028
|
| View |
|
DR-XY42170
|
Isoxsuprine Hydrochloride
|
Duvapar
|
10mg
|
Tablet
|
-
|
Par Laboratories
|
India
|
-
|
05 October 2020
|
27 June 2025
|
| View |
|
DR-XY42179
|
Ciprofloxaxin (as hydrochloride) + Dexamethasone
|
Acipredex
|
3 mg/1 mg / mL (0.3% w/v / 0.1% w/v)
|
Ophthalmic Suspension (Drops)
|
Antibacterials (Fluoroquinolones in combination with Corticosteroids)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 May 2023
|
28 June 2028
|
| View |
|
DR-XY42185
|
Pregabalin
|
Funxion
|
50 mg
|
Capsule
|
Antiepileptic
|
Ajanta Pharma Limited
|
India
|
Automatic Renewal
|
21 July 2023
|
08 July 2028
|
| View |
|
DR-XY42189
|
Lidocaine Hydrochloride + Epinephrine (Local Infiltration)
|
FD
|
20 mg/10 mcg
|
Solution For Injection
|
Local Anesthetic
|
Laboratories Zeyco S.A. de C.V
|
Mexico
|
Automatic Renewal
|
11 June 2023
|
08 July 2028
|
| View |
|
DR-XY42199
|
Cefixime (As Trihdyrate)
|
Refix
|
100 mg/5 mL
|
Granules For Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
14 April 2023
|
10 July 2028
|
| View |
|
DR-XY42200
|
Potassium Chloride
|
Kaltrol
|
150mg/mL (2meq/mL)
|
Solution For Injection
|
Electrolyte or IV Additive Solution Solution
|
Zhejiang Tianrui Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
26 July 2023
|
10 July 2028
|
| View |
|
DR-XY42217
|
Peritoneal Dialysis Solution + 4.25% Dextrose Solution
|
Unbranded
|
|
Solution For Iv Infusion
|
Peritoneal Dialysis Solution
|
Shanxi Zhen Dong Taisheng Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
01 August 2023
|
18 July 2028
|
| View |
|
DR-XY42222
|
Famotidine
|
Voker
|
20 mg
|
Film-Coated Tablet
|
H2-Receptor Antagonist
|
Y.S.P. Industries (M) Sdn. Bhd
|
Malaysia
|
Renewal
|
10 August 2023
|
18 July 2028
|
| View |
|
DR-XY42229
|
Cetirizine (as Hydrochloride)
|
Askey Dt
|
5 mg
|
Disperable Tablet
|
HI- Receptor Antagonist ( Antihistamine)
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
29 March 2023
|
15 July 2028
|